Bashash, Davood <br/><br/>
Anti-tumor activity of PI3K-δ inhibitor in hematologic malignant cells: Shedding new light on resistance to Idelalisib.  [electronic resource] 

 -  The international journal of biochemistry & cell biology  04 2017 
 - 149-158 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1878-5875 
<br/><br/><label>Standard No.: </label>10.1016/j.biocel.2017.02.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Arsenic Trioxide<br/>Arsenicals--pharmacology<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Drug Resistance, Neoplasm<br/>Drug Synergism<br/>Gene Expression Regulation--drug effects<br/>Humans<br/>Inhibitor of Apoptosis Proteins--genetics<br/>Myeloid Cell Leukemia Sequence 1 Protein--genetics<br/>Oxides--pharmacology<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Protein Kinase Inhibitors--pharmacology<br/>Purines--pharmacology<br/>Quinazolinones--pharmacology<br/>Survivin